Managing Editor
@ShahidNShah
@ShahidNShah
Unequal Diffusion of Medical Innovation: New Medications, Old Problems
The majority of adults in the United States (US) have at least one chronic disease, and treating these diseases accounts for nearly 90% of health expenditures. Chronic cardiometabolic conditions, such as diabetes and ischemic heart disease, are especially important drivers of health as they represent leading causes of both disability and mortality in the US and globally.
Medigy Insights
New medical innovations—such as newer medications—often spread unevenly across populations, with access influenced by factors like socioeconomic status and healthcare disparities.
Continue reading at link.springer.com
Make faster decisions with community advice
- Challenges and Benefits of Hospital-at-Home Care in Iran from Providers and Patients’ Insights
- Digital Health Applications Development: A Complete Guide for 2025
- Enhancing Interprofessional Team Performance to Prevent Medication Errors in Emergency Care: Quasi-Experimental Study Using Multimodal Virtual Simulation-Based Interprofessional Education
- Evaluating AI-Generated Geriatric Case Studies for Interprofessional Education: Systematic Analysis Across 5 Platforms
- Quantifying the Dynamics of Innovation Abandonment Across Scientific, Technological, Commercial, and Pharmacological Domains
Next Article
-
Quantifying the Dynamics of Innovation Abandonment Across Scientific, Technological, Commercial, and Pharmacological Domains
Despite the vast literature on the diffusion of innovations that impacts a broad range of disciplines, our understanding of the abandonment of innovations remains limited yet is essential for a deeper …
